The North America sepsis diagnostics market is expected to grow from US$ 279.06 million in 2021 to US$ 513.33 million by 2028. It is estimated to record a CAGR of 9.1% from 2021 to 2028.
High Incidence of Sepsis due to Increasing Nosocomial Infections Drives North America Sepsis Diagnostics Market
The primary trigger for sepsis is infection, with a disproportionately higher risk observed in immunocompromised individuals, including those undergoing chemotherapy, post-splenectomy patients, and those with conditions like AIDS, diabetes, and other chronic diseases. Notably, nosocomial infections are a leading cause of morbidity and mortality within hospital settings. According to the Centers for Disease Control and Prevention’s (CDC) “2020 National and State Healthcare-Associated Infections Progress Report” (2021), the US experienced increases of approximately 24% in central line-associated bloodstream infections, 35% in ventilator-associated events, and 15% in Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia between 2019 and 2020. The Global Sepsis Alliance (GSA) indicates that around 26 million people worldwide develop sepsis annually, leading to about 8 million deaths. Therefore, the increasing occurrence of bloodstream infections is likely to drive greater utilization of sepsis diagnostic products. Additionally, mortality often stems from diarrheal diseases or lower respiratory infections, and early diagnosis coupled with suitable clinical management can prevent many fatalities. Consequently, the high incidence of sepsis is projected to stimulate the need for sepsis diagnostic products, thereby driving the expansion of the North America sepsis diagnostics industry during the forecast period.
Download our Sample PDF Report
@ https://www.businessmarketinsights.com/sample/BMIRE00025664
North America Sepsis Diagnostics Strategic Insights
Strategic insights for the North America Sepsis Diagnostics sector deliver analysis grounded in data regarding the industry’s environment, including current trends, significant players, and regional specificities. These insights provide practical recommendations, allowing readers to distinguish themselves from competitors by spotting underserved segments or creating novel value propositions. Utilizing data analytics, these insights help industry participants—be they investors, manufacturers, or other stakeholders—to foresee market changes. A forward-looking view is essential, helping stakeholders anticipate market shifts and strategically position themselves for long-term success in this dynamic region. Ultimately, impactful strategic insights enable readers to make informed decisions that enhance profitability and achieve their business objectives within the market.
North America Sepsis Diagnostics Market Segmentation
North America Sepsis Diagnostics Market: By Product
- Instruments
- Reagents and Assays
- Blood Culture Media
- Software
North America Sepsis Diagnostics Market: By Technology
- Molecular Diagnostics
North America Sepsis Diagnostics Market: By Flow
- (Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
North America Sepsis Diagnostics Market: By Method
- Automated Diagnostics and Conventional Diagnostics
North America Sepsis Diagnostics Market: By Test Type
- Point-of-Care Tests and Laboratory Tests
North America Sepsis Diagnostics Market: Regions and Countries Covered
North America
- US
- Canada
- Mexico
North America Sepsis Diagnostics Market: Market leaders and key company profiles
- Abbott
- BD
- bioMerieux SA
- Danaher (Beckman Coulter)
- F. HOFFMANN-LA ROCHE LTD.
- Immunexpress Inc.
- Luminex Corporation
- T2 Biosystems, Inc.
- THERMO FISHER SCIENTIFIC INC.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
